Heart Attack (Myocardial Infarction) News and Research

RSS
A Heart Attack (Myocardial Infarction) occurs when blood flow to a section of heart muscle becomes blocked. If the flow of blood isn’t restored quickly, the section of heart muscle becomes damaged from lack of oxygen and begins to die.

Heart attack is a leading killer of both men and women in the United States. But fortunately, today there are excellent treatments for heart attack that can save lives and prevent disabilities. Treatment is most effective when started within 1 hour of the beginning of symptoms. Heart attacks occur most often as a result of a condition called coronary artery disease (CAD). In CAD, a fatty material called plaque (plak) builds up over many years on the inside walls of the coronary arteries (the arteries that supply blood and oxygen to your heart). Eventually, an area of plaque can rupture, causing a blood clot to form on the surface of the plaque. If the clot becomes large enough, it can mostly or completely block the flow of oxygen-rich blood to the part of the heart muscle fed by the artery.
Traffic fumes can raise risk for heart attack for at least six hours: Study

Traffic fumes can raise risk for heart attack for at least six hours: Study

Synthon announces European approvals for Eplerenone

Synthon announces European approvals for Eplerenone

Data on veterans affairs hospitals shows high rates of readmissions

Data on veterans affairs hospitals shows high rates of readmissions

Australia’s Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Australia’s Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Longer CPR may do more harm than good: Study

Longer CPR may do more harm than good: Study

Foods that can reduce cholesterol

Foods that can reduce cholesterol

Psoriasis drug and heart attack risk association unclear: Study

Psoriasis drug and heart attack risk association unclear: Study

Trophos awarded US patent covering use of novel cardioprotective compound

Trophos awarded US patent covering use of novel cardioprotective compound

Faster angioplasty for most heart attack victims: Study

Faster angioplasty for most heart attack victims: Study

Bear bile compound may help treat heart attack: Study

Bear bile compound may help treat heart attack: Study

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

Hormone therapy may be hazardous in men with pre-existing heart conditions

Hormone therapy may be hazardous in men with pre-existing heart conditions

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

FDA approves AstraZeneca's anti-clotting drug Brilinta

FDA approves AstraZeneca's anti-clotting drug Brilinta

Stopping Aspirin may raise heart attack death risk by 60%: Study

Stopping Aspirin may raise heart attack death risk by 60%: Study

Heaviest meals on the menu

Heaviest meals on the menu

Married men with heart attack seek help sooner: Study

Married men with heart attack seek help sooner: Study

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack